Literature DB >> 20955777

Social isolation is associated with elevated tumor norepinephrine in ovarian carcinoma patients.

Susan K Lutgendorf1, Koen DeGeest, Laila Dahmoush, Donna Farley, Frank Penedo, David Bender, Michael Goodheart, Thomas E Buekers, Luis Mendez, Gina Krueger, Lauren Clevenger, David M Lubaroff, Anil K Sood, Steve W Cole.   

Abstract

Noradrenergic pathways have been implicated in growth and progression of ovarian cancer. Intratumoral norepinephrine (NE) has been shown to increase with stress in an animal cancer model, but little is known regarding how tumor NE varies with disease stage and with biobehavioral factors in ovarian cancer patients. This study examined relationships between pre-surgical measures of social support, depressed mood, perceived stress, anxiety, tumor histology and tumor catecholamine (NE and epinephrine [E]) levels among 68 ovarian cancer patients. We also examined whether associations observed between biobehavioral measures and tumor catecholamines extended to other compartments. Higher NE levels were found in advanced stage (p=0.006) and higher grade (p=0.001) tumors. Adjusting for stage, grade, and peri-surgical beta blockers, patients with a perceived lack of social support had significantly higher tumor NE (β=-0.29, p=0.012). A similar trend was seen for social support and ascites NE (adjusting for stage, peri-surgical beta blockers and caffeine: β=-0.50, p=0.075), but not for plasma NE. Other biobehavioral factors were not related to tumor, ascites, or plasma NE (p values >0.21). Tumor E was undetectable in the majority of tumors and thus E was not further analyzed. In summary, these results suggest that tumor NE provides distinct information from circulating plasma concentrations. Tumor NE levels were elevated in relationship to tumor grade and stage. Low subjective social support was associated with elevated intratumoral NE. As beta-adrenergic signaling is related to key biological pathways involved in tumor growth, these findings may have implications for patient outcomes in ovarian cancer. Copyright Â
© 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20955777      PMCID: PMC3103818          DOI: 10.1016/j.bbi.2010.10.012

Source DB:  PubMed          Journal:  Brain Behav Immun        ISSN: 0889-1591            Impact factor:   7.217


  35 in total

Review 1.  Physiology and neurobiology of stress and adaptation: central role of the brain.

Authors:  Bruce S McEwen
Journal:  Physiol Rev       Date:  2007-07       Impact factor: 37.312

Review 2.  Personality and risk of physical illness.

Authors:  Timothy W Smith; Justin MacKenzie
Journal:  Annu Rev Clin Psychol       Date:  2006       Impact factor: 18.561

3.  Social networks, social support, and survival after breast cancer diagnosis.

Authors:  Candyce H Kroenke; Laura D Kubzansky; Eva S Schernhammer; Michelle D Holmes; Ichiro Kawachi
Journal:  J Clin Oncol       Date:  2006-03-01       Impact factor: 44.544

4.  At risk on the cusp of old age: living arrangements and functional status among black, white and Hispanic adults.

Authors:  L J Waite; M E Hughes
Journal:  J Gerontol B Psychol Sci Soc Sci       Date:  1999-05       Impact factor: 4.077

5.  Stress hormone-mediated invasion of ovarian cancer cells.

Authors:  Anil K Sood; Robert Bhatty; Aparna A Kamat; Charles N Landen; Liz Han; Premal H Thaker; Yang Li; David M Gershenson; Susan Lutgendorf; Steven W Cole
Journal:  Clin Cancer Res       Date:  2006-01-15       Impact factor: 12.531

6.  Loneliness as a specific risk factor for depressive symptoms: cross-sectional and longitudinal analyses.

Authors:  John T Cacioppo; Mary Elizabeth Hughes; Linda J Waite; Louise C Hawkley; Ronald A Thisted
Journal:  Psychol Aging       Date:  2006-03

7.  The effects of depressive symptoms on cardiovascular and catecholamine responses to the induction of depressive mood.

Authors:  Mark Hamer; Gohichi Tanaka; Hisayoshi Okamura; Akira Tsuda; Andrew Steptoe
Journal:  Biol Psychol       Date:  2006-07-24       Impact factor: 3.251

8.  Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma.

Authors:  Premal H Thaker; Liz Y Han; Aparna A Kamat; Jesusa M Arevalo; Rie Takahashi; Chunhua Lu; Nicholas B Jennings; Guillermo Armaiz-Pena; James A Bankson; Murali Ravoori; William M Merritt; Yvonne G Lin; Lingegowda S Mangala; Tae Jin Kim; Robert L Coleman; Charles N Landen; Yang Li; Edward Felix; Angela M Sanguino; Robert A Newman; Mary Lloyd; David M Gershenson; Vikas Kundra; Gabriel Lopez-Berestein; Susan K Lutgendorf; Steven W Cole; Anil K Sood
Journal:  Nat Med       Date:  2006-07-23       Impact factor: 53.440

9.  Depression and anxiety symptoms are related to increased 24-hour urinary norepinephrine excretion among healthy middle-aged women.

Authors:  Joel W Hughes; Lana Watkins; James A Blumenthal; Cynthia Kuhn; Andrew Sherwood
Journal:  J Psychosom Res       Date:  2004-10       Impact factor: 3.006

10.  Norepinephrine up-regulates the expression of vascular endothelial growth factor, matrix metalloproteinase (MMP)-2, and MMP-9 in nasopharyngeal carcinoma tumor cells.

Authors:  Eric V Yang; Anil K Sood; Min Chen; Yang Li; Tim D Eubank; Clay B Marsh; Scott Jewell; Nicholas A Flavahan; Carl Morrison; Peir-En Yeh; Stanley Lemeshow; Ronald Glaser
Journal:  Cancer Res       Date:  2006-11-01       Impact factor: 12.701

View more
  79 in total

Review 1.  Biobehavioral factors and cancer progression: physiological pathways and mechanisms.

Authors:  Susan K Lutgendorf; Anil K Sood
Journal:  Psychosom Med       Date:  2011-10-21       Impact factor: 4.312

2.  Chronic exposure to stress hormones promotes transformation and tumorigenicity of 3T3 mouse fibroblasts.

Authors:  Melanie S Flint; Andrew Baum; Britteny Episcopo; Kelly Z Knickelbein; Angela J Liegey Dougall; William H Chambers; Frank J Jenkins
Journal:  Stress       Date:  2012-05-16       Impact factor: 3.493

Review 3.  Sympathetic nervous system regulation of the tumour microenvironment.

Authors:  Steven W Cole; Archana S Nagaraja; Susan K Lutgendorf; Paige A Green; Anil K Sood
Journal:  Nat Rev Cancer       Date:  2015-09       Impact factor: 60.716

Review 4.  Mild cold-stress depresses immune responses: Implications for cancer models involving laboratory mice.

Authors:  Michelle N Messmer; Kathleen M Kokolus; Jason W-L Eng; Scott I Abrams; Elizabeth A Repasky
Journal:  Bioessays       Date:  2014-07-25       Impact factor: 4.345

5.  Neighborhood and Family Environment of Expectant Mothers May Influence Prenatal Programming of Adult Cancer Risk: Discussion and an Illustrative DNA Methylation Example.

Authors:  Katherine E King; Jennifer B Kane; Peter Scarbrough; Cathrine Hoyo; Susan K Murphy
Journal:  Biodemography Soc Biol       Date:  2016

6.  Stressing the need to overcome EGFR tyrosine kinase inhibitor resistance.

Authors:  Leila Toulabi; Bríd M Ryan
Journal:  Transl Lung Cancer Res       Date:  2018-04

Review 7.  The impact of psychosocial stress and stress management on immune responses in patients with cancer.

Authors:  Michael H Antoni; Firdaus S Dhabhar
Journal:  Cancer       Date:  2019-02-15       Impact factor: 6.860

8.  Depression Stresses the Immune Response and Promotes Prostate Cancer Growth.

Authors:  Hemn Mohammadpour; Mark J Bucsek; Bonnie L Hylander; Elizabeth A Repasky
Journal:  Clin Cancer Res       Date:  2019-01-22       Impact factor: 12.531

9.  Social influences on clinical outcomes of patients with ovarian cancer.

Authors:  Susan K Lutgendorf; Koen De Geest; David Bender; Amina Ahmed; Michael J Goodheart; Laila Dahmoush; M Bridget Zimmerman; Frank J Penedo; Joseph A Lucci; Parvin Ganjei-Azar; Premal H Thaker; Luis Mendez; David M Lubaroff; George M Slavich; Steven W Cole; Anil K Sood
Journal:  J Clin Oncol       Date:  2012-07-16       Impact factor: 44.544

10.  Biobehavioral modulation of the exosome transcriptome in ovarian carcinoma.

Authors:  Susan K Lutgendorf; Premal H Thaker; Jesusa M Arevalo; Michael J Goodheart; George M Slavich; Anil K Sood; Steve W Cole
Journal:  Cancer       Date:  2017-11-07       Impact factor: 6.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.